Holen Sie sich die Stockscreener-App
42.88
1.22%
-0.53
Handel nachbörslich:
43.54
0.66
+1.54%
Medline Inc Aktie (MDLN) Neueste Nachrichten
Medline (MDLN) Q4 net sales rise 14.8% to $7.8B following completion of IPO - MSN
Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO - Insider Monkey
Medline Awards Distribution Center of the Year and SAFE Awards - marketscreener.com
Medline stock price target raised to $60 by Tigress Financial - Investing.com
Medline prices $3B secondary offering at $41 per share - MSN
Medline stock price target reaffirmed at $55 by BTIG - Investing.com
Medline Inc. announces pricing of secondary offering of class A common stock - Sahm
Medline’s buyout firm backers raise $3.1B in share sale - Crain's Chicago Business
Medline’s PE owners cash out US$3.1bn in early lockup release - ifre.com
Medline Secondary Common Stock Offering Prices; Shares Down Pre-Bell - marketscreener.com
Medline stockholders price secondary offering at $41 per share By Investing.com - Investing.com Australia
Medline stockholders price secondary offering at $41 per share - Investing.com
Medline’s Buyout Firm Backers Raise $3.1 Billion in Share Sale - Bloomberg.com
Medline Inc. Announces Pricing Of Secondary Offering Of Class A Common Stock - TradingView
Shareholders of the American Medline intend to sell shares worth $ 3.4 billion - AKM.RU
Ear Syringe Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Medline Backers Launch $3.4B Secondary Sale Near Chicago - Hoodline
Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For MedlineMedline (NASDAQ:MDLN) - Benzinga
Medline’s PE backers start stake sale worth $3.4 billion - Crain's Chicago Business
Medline Shareholders Seek $3.4 Billion Stake Sale - Transport Topics
Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg
Medline stockholders launch 75 million share offering - Investing.com
Medline shares fall 4.4% as major investors launch secondary offering By Investing.com - Investing.com Nigeria
Medline stockholders launch 75 million share offering By Investing.com - Investing.com Canada
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Medline Inc. announces launch of secondary offering of Class A common stock - GlobeNewswire
Form S-1 Medline Inc. - StreetInsider
USA Herald - USA Herald
The 20+ Club: Ron Woosley - Medline Newsroom
Medline expands AI platform and warehouse robotics - Digital Commerce 360
Medline Inc.: Fundamental Analysis and Financial Ratings | MDLN | US58507V1070 - marketscreener.com
The Analyst Verdict: Medline In The Eyes Of 29 Experts - Benzinga
Wells Fargo & Company Increases Medline (NASDAQ:MDLN) Price Target to $47.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... By GuruFocus - Investing.com Canada
Medline Analysts Boost Their Forecasts Following Q4 Results - Benzinga
Medline (NASDAQ:MDLN) Given New $54.00 Price Target at BMO Capital Markets - MarketBeat
Medline boasts $2.4B in new customer signings in 2025 - HME News
Wolfe Research raises Medline stock price target on revenue beat By Investing.com - Investing.com India
Wolfe Research raises Medline stock price target on revenue beat - Investing.com
CEO of Northfield-based Medline talks tariffs, IPO following company’s first earnings call - Chicago Tribune
Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… - marketscreener.com
Evercore ISI Maintains Outperform on Medline Inc (MDLN) Feb 25 2026 - Meyka
Medline's first quarter as a public company ends with rising sales, dip in income - Crain's Chicago Business
Medline Inc. SEC 10-K Report - TradingView
Stifel raises Medline stock price target to $55 on strong results - Investing.com
Medline Q4 Earnings Call Highlights - MarketBeat
Evercore ISI raises Medline stock price target on strong momentum By Investing.com - Investing.com South Africa
Evercore ISI raises Medline stock price target on strong momentum - Investing.com
Robust Q4 Beat and Underappreciated 2026 Upside Support Buy Rating on Medline - TipRanks
2.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):